跳至主要内容
临床试验/NCT02359578
NCT02359578已完成早期 1 期

The Occlusion Pressure of Superficial Lymphatics in the Upper Extremity of Healthy Volunteers: A Near Infrared Lymphofluoroscopy Approach

Centre Hospitalier Universitaire Saint Pierre1 个研究点 分布在 1 个国家目标入组 32 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
32
试验地点
1
主要终点
Lymph flow active or not depending on the pressure applied

研究概览

简要总结

The lymphatic system is one of the keystones of fluid homeostasis in the interstitium. In analogy with the arterial systolic pressure, the lymphatic systolic pressure can give us information about the functioning of the cardiovascular system and fluid exchange. Actually, knowledge about this physiological parameter is incomplete because of the lack of technology. Former measurement techniques of the lymphatic systolic pressure in the living healthy man were invasive and too complex to be interpreted.

The lymphatic occlusion pressure has to be clarified because lymphedema treatment, concerning the pressure to be applied on the edematous tissue is still based on controversial concepts.

On one hand, techniques such as Manual Lymphatic Drainage, sustain the necessity to apply a very low pressure in order to avoid the squeezing of superficial lymph vessels. On the other hand sustainers of Intermittent Compression Therapy advocate the necessity to apply relatively high pressure to obtain a decongesting effect. These completely opposite opinions triggered us to study lymphatic pressure more thoroughly.

Lymphofluoroscopy (emerging imaging technique in the field of lymphology) is now used since 3 years by the promoters of this study to visualize the architecture of the superficial lymphatic network and the progression of the lymph inside the highlighted vessels. This technique will be used in the present (prospective and multicentric) study to observe the effect of a pressure applied on the limb on the displacement of the lymph, and then to determine the occlusion pressure of the lymphatic vessels.

详细描述

Injection of contrast agent Indocyanine Green (ICG) is a tricarbocyanine dye that is commonly used for hepatic, cardiovascular, plastic surgery and ophthalmology applications. It is usually injected intravenously at a dose comprised between 0.1 and 0.5 mg/kg. After administration, ICG binds to plasmatic proteins, lipoproteins and lipids, and is thereafter rapidly and completely cleared from blood by the liver. ICG is excited and emits fluorescence in the near-infrared (around 760 nm).

In this study, we will suspend ICG in 25 ml pure water and subsequently diluted with pure water to reach a final concentration of 1 mg/ml. Each subject will receive a subcutaneous injection of 0.2 ml of diluted ICG (e.i. 200µg), using a hypodermic needle. We will standardize the injection point and inject ICG subcutaneously in the first interdigital space, according to the injection method used for lymphoscintigraphy. In this way, we highlight systematically the same area of the superficial lymphatic network.

We know that in the upper limbs, lateralization or handedness coincides with functional (and/or anatomical) asymmetries. To avoid any bias, the injected arm in healthy patients will be randomized tossing heads or tails.

Fluorescence images acquisition After injection, the injection sites will be covered with tape to avoid camera oversaturation, and to avoid spreading of ICG on the skin and undesirable fluorescent background on the images. To obtain fluorescence imaging of arm lymphatic flow, a near-infrared fluorescence imaging system will be used (Photo Dynamic Eye, or PDE camera from Hammamatsu Photonics - Japan). The camera is maintained in a fix position, 15 cm above the investigation field, by a holding system from Noga Tools. The amplified analogic signal is transformed into a digital signal by a converter from Terratec (Model Grabster AV 450 MX) and transferred to a monitor, which allows to visualize lymphatic network and lymph flow in real-time. Images will be recorded on a dedicated external hard disk drive Iomega, model MDHDU.

The session will take place in a dark room, to allow NIR fluorescence images acquisition.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Healthy volunteers
  • Written informed consent signed

排除标准

  • Coronary disease
  • Pregnancy
  • Allergy to iodine or to shellfish
  • Breastfeeding
  • Advanced renal impairment
  • Thyroid pathology
  • Primary and secondary lymphedema anywhere on the body
  • Oncologic history
  • Familial lymphedema
  • Previous surgery on the studied member, causing risk of a subclinical lymphedema

研究组 & 干预措施

Lymphatic occlusion pressure

Experimental

injection of 100µg Indocyanine Green in the first interdigital space and application of increasing pressure around the arm to visualize at which pressure lymph flow is interrupted.

干预措施: Indocyanine Green (Drug)

结局指标

主要结局

Lymph flow active or not depending on the pressure applied

时间窗: 1 minute

Study of the influence of an applied pressure on this upper limb on the progression of the lymph in this limb, using a sphygmomanometer.

次要结局

未报告次要终点

研究者

发起方
Centre Hospitalier Universitaire Saint Pierre
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验